Solara Active Pharma Science is currently trading at Rs. 424.75, up by 4.20 points or 1.00% from its previous closing of Rs. 420.55 on the BSE.
The scrip opened at Rs. 424.00 and has touched a high and low of Rs. 430.50 and Rs. 421.00 respectively. So far 1705 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 491.80 on 03-Jun-2019 and a 52 week low of Rs. 275.10 on 05-Aug-2019.
Last one week high and low of the scrip stood at Rs. 432.00 and Rs. 420.00 respectively. The current market cap of the company is Rs. 1109.32 crore.
The promoters holding in the company stood at 40.55%, while Institutions and Non-Institutions held 21.64% and 37.81% respectively.
Solara Active Pharma Sciences is going to carry out internal probe on Nizatidine API amid the voluntary recall of Nizatidine API by Mylan. The company is in the process of collecting corresponding lots of API from Mylan to carry out internal investigation.
Mylan N.V.'s US based Mylan Pharmaceuticals (Mylan) has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150mg and 300mg strengths) due to detected trace amounts of impurity N-nitrosodimethylamine (NDMA) contained in the Nizatidine API. Mylan also indicated that the recall is voluntary, and the company has not received any reports of adverse events related to these batches to date.
Solara Active Pharma Sciences’ last supplies of Nizatidine API to Mylan were made in September 2017.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |